Josef Vagner
15Patents
3h-index
37Co-inventors
60Inventor score
Filing activity: Mar 9, 1999 → Jan 24, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6503949B1 | Glucagon antagonists/inverse agonists | Chemistry; Metallurgy | 35 | Expired |
| US6225329A | Modulators of protein tyrosine phosphatases (PTPases) | Chemistry; Metallurgy | 25 | Expired |
| US10406248B2 | Molecular imaging of cancer cells in vivo | Chemistry; Metallurgy | 3 | Active |
| US10793595B2 | Toll-like receptor 2 ligands and methods of making and using thereof | Human Necessities | 2 | Active |
| US10118942B2 | Toll-like receptor 2 ligands and methods of making and using thereof | Human Necessities | 2 | Active |
| US9441013B2 | Melanocortin 1 receptor ligands and methods of use | Human Necessities | 1 | Active |
| US11414455B2 | Toll-like receptor 2 ligands and methods of making and using thereof | Human Necessities | 0 | Active |
| US11230568B2 | Melanocortin 1 receptor ligands and methods of use | Human Necessities | 0 | Active |
| US10329326B2 | Melanocortin 1 receptor ligands and methods of use | Human Necessities | 0 | Active |
| US10308656B2 | Small molecule inhibitors of Ku70/80 and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12173087B2 | Melanocortin 1 receptor ligands and methods of use | Human Necessities | 0 | Active |
| US11952379B2 | Small molecule modulators of PAR2 and uses thereof | Human Necessities | 0 | Active |
| US11458212B2 | Molecular imaging of cancer cells in vivo | Chemistry; Metallurgy | 0 | Active |
| US11351264B2 | PAR2 mimetic peptides and uses thereof | Human Necessities | 0 | Active |
| US11306130B2 | PAR3 mimetic peptides and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.